BMP-2/4, members in TGF-beta superfamily, are potent growth factors in inducing osteoblast differentiation and stimulating bone formation. Signaling in TGF-beta superfamily is mediated by direct phosphorylation of Smad proteins. Smad2 and Smad3 are phosphorylated by TGF-beta and activin receptors, whereas phosphorylation of Smad 1 is specifically induced by bone morphogenetic proteins. Upon phosphorylation these Smad proteins interact with a common partner, Smad4, and translocate into the nucleus where the complex recruits DNA binding protein(s) to activate specific gene transcription. However, the DNA binding protein(s) involved in BMP signaling has not been identified. We have demonstrated that BMPs induce the interaction of Smad1 with Hoxc-8, a member of the homeodomainn transcription factor family. The interaction of Smad l with Hoxc-8 inhibits the binding of Hoxc-8 to its DNA binding site. Hoxc-8 functions as a transcription repressor. A hox binding site is characterized from the 5- flanking region of osteopontin gene, and BMP-induced osteopontin gene transcription is mediated through this Hox binding site. We hypothesize that BMP-2/4 induces osteoblast cell differentiation mediated by the Smad1 interaction with Hoxc-8.
The specific aims proposed are to:l) characterize the specificity of the interaction between Smad1 and Hox proteins in BMP2/4 signaling; 2) map domains that are responsible for the interaction between Smad1 and Hoxc8. The effect of mapped Smad1 interaction domains) on gene transcription will also be assessed in luciferase reporter transfection studies. 3) Characterize the effects of the interaction between Smad1 and Hoxc-8 on osteoblast differentiation in human primary stro-1 cells. Further characterization of the interaction between Smad1 and Hoxc-8 will help us to understand the mechanism of BMP signaling and may yield a potential drug target to stimulate bone formation in osteoporosis patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK057501-04
Application #
6692229
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Program Officer
Malozowski, Saul N
Project Start
2001-01-01
Project End
2005-09-14
Budget Start
2004-01-01
Budget End
2005-09-14
Support Year
4
Fiscal Year
2004
Total Cost
$249,533
Indirect Cost
Name
University of Alabama Birmingham
Department
Pathology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Xu, Xin; Zheng, Liwei; Yuan, Quan et al. (2018) Transforming growth factor-? in stem cells and tissue homeostasis. Bone Res 6:2
Xie, Liang; Tintani, Francis; Wang, Xiao et al. (2016) Systemic neutralization of TGF-? attenuates osteoarthritis. Ann N Y Acad Sci 1376:53-64
Cui, Zhuang; Crane, Janet; Xie, Hui et al. (2016) Halofuginone attenuates osteoarthritis by inhibition of TGF-? activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 75:1714-21
Bian, Qin; Jain, Amit; Xu, Xin et al. (2016) Excessive Activation of TGF? by Spinal Instability Causes Vertebral Endplate Sclerosis. Sci Rep 6:27093
Qiu, Tao; Xian, Lingling; Crane, Janet et al. (2015) PTH receptor signaling in osteoblasts regulates endochondral vascularization in maintenance of postnatal growth plate. J Bone Miner Res 30:309-17
Xu, Xin; Zheng, Liwei; Bian, Qin et al. (2015) Aberrant Activation of TGF-? in Subchondral Bone at the Onset of Rheumatoid Arthritis Joint Destruction. J Bone Miner Res 30:2033-43
Xie, Hui; Cui, Zhuang; Wang, Long et al. (2014) PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 20:1270-8
Crane, Janet L; Cao, Xu (2014) Bone marrow mesenchymal stem cells and TGF-? signaling in bone remodeling. J Clin Invest 124:466-72
Crane, Janet L; Cao, Xu (2014) Function of matrix IGF-1 in coupling bone resorption and formation. J Mol Med (Berl) 92:107-15
Zhen, Gehua; Cao, Xu (2014) Targeting TGF? signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci 35:227-36

Showing the most recent 10 out of 28 publications